Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation [2]

Sunil Nadar, Andrew Blann, Gregory Y.H. Lip*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation [2]'. Together they form a unique fingerprint.